Phase 1 clinical trials
Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
At the time the article was last revised Henry Knipe had no recorded disclosures.View Henry Knipe's current disclosures
Phase 1 clinical trials, occur after a drug successfully passes phase 0 trials, and aim to assess dosage, safety and identify side effects. They are performed typically on 20–80 individuals.